PharmaVOICE - 
October 2015
Purchase Issue

In Every Issue
Letter from the Editor
Crowdsourcing is a social phenomenon that is providing a platform [...]
By

Taren Grom, Editor

UpFront
Industry at Large Daiichi Sankyo Provides Support to China Daiichi [...]
By

PharmaVOICE Staff

Innovator’s Corner
An App Store for Genomic Information Justin Kao, Senior VP [...]
By

Justin Kao, Senior VP of Corporate Development, Operations, and Strategy at Helix,

The Network
Wearables Market Continues to Expand Trending Now: Wearables technology is [...]
By

PharmaVOICE Staff

What’s New
Critical Path Institute Establishes the Global Pediatric Clinical Trials Network [...]
By

PharmaVOICE Staff

Pharma Trax
Payer Pressures, Market Access Weigh Upon Life-Sciences Strategy  Trending Now: [...]
By

PharmaVOICE Staff

Tools of the Trade
FusionOps Launches Supply Chain Analytics Trending Now:  Cloud solution provides [...]
By

PharmaVOICE Staff

The Calendar
Coming Attractions CNS Summit 2015 will take place Oct. 8 [...]
By

PharmaVOICE Staff

Talent Pool
Pharma Pool Susan Benton Tracey Dawson Shire Appoints New Executive [...]
By

PharmaVOICE Staff

Last Word
Communications and  Public Health Gil Bashe, Chair of the American [...]
By

Gil Bashe, Chair of the American Heart Association

On The Cover

R&D Moves Slowly Toward Open Source
Open access and crowdsourcing scientific information to accelerate research and development requires a new way of thinking about how clinical research is conducted and breaking down competitive barriers for the greater good. Crowdsourcing is the process of getting work or funding, usually online, from a crowd of people. This mainstream social experiment, which has been [...]
By

Denise Myshko

Features

Show Don’t Tell: Messaging in the Digital Age
In 1911, a newspaper editor was the first to use the phrase “A picture is worth a thousand words,” and the relevance of this statement remains today. More than 100 years later, it is even more important to represent a brand or brand message in as quick and visual a way as possible, especially online. [...]
By

Robin Robinson

Beyond Medical Marijuana
The broad reaching war on drugs that began more than 40 years ago had an unintended consequence: research on the therapeutic value of controlled substances such marijuana, psychedelics, narcotics, and stimulants stalled. Controlled substances were difficult for researchers to get and research was often surrounded by controversy. But this mindset is changing, and there is [...]
By

Denise Myshko

Oncology Marketing Based On Value
As more payers turn to an indication-based or pay-for-performance based model to manage the costs of oncology care, oncology marketers will need to adjust their strategies to include a more holistic, value-based message. Across the globe, the trend toward more innovative payment models has altered the way oncology treatments are being evaluated, not only by [...]
By

Robin Robinson

Aging Well
With more than 10,000 people a day turning 65 in the United States, the industry is preparing to meet the demand of this older population. Two avenues include exploring regenerative medicine, and tailoring digital strategies to this online-savvy demographic. To meet the upcoming demand from the nearly 2 billion people over 60, pharma and biotech [...]
By

Robin Robinson

Balancing Risk and Reward in Nigeria
As the largest economy in West Africa based on gross domestic product (GDP), Nigeria is emerging as an exciting market for all industries. According to 2013 figures, Nigeria’s GDP is around 0 billion, stronger even than South Africa with a GDP of around 0 billion. Today, Nigeria is the 26th largest economy in the world. [...]
By

Kim Ribbink

SHOWCASE FEATURE: Patient Solutions
Patient solutions can be as varied as the different stages of the disease “journey” that patients are experiencing: beginning with the first symptoms, continuing to diagnosis, then to treatment choice and optimization and eventually the improved life with disease. Additionally, all of those steps and stages are different from one disease to another one. Some [...]
By

Taren Grom, Editor

Not all Rx Adherence Solutions are Created Equal
In a world where the majority — 60% to 80% — of people don’t follow their prescribed treatment, pharma manufacturers continue to struggle to address the health consequences and financial burden of non- adherence. Education, reminder tactics, points for prizes and gaming techniques; there are many options positioned as solutions. Yet, not all adherence solutions [...]
By

Jennifer Sigaud, Managing Director, US, Atlantis Healthcare

Bridging the Gap Between Patients and Providers for Better Health Outcomes
Pharma has expanded the scope of patient solutions in the marketplace, but most of these solutions remain product-focused. The emphasis is currently on product messaging or tools to make access to products more convenient and easier for the patient. Sure, these solutions can enhance the product experience, but do they really add any real value [...]
By

Alyson Connor, President, MicroMass Communications, Inc.

Mission No. 1: Making the World a Better Place
“The world would be a better place…”  It’s a short phrase that can provoke powerful thought experiments… and can even transform the way we live. At Ogilvy, and Ogilvy CommonHealth Worldwide, we start all of our discussions with this simple framework. The world would be a better place, if… And when the topic is patient-centricity, [...]
By

Johanna Skilling, Executive VP, Director of Planning, US, Ogilvy CommonHealth Worldwide

SHOWCASE FEATURE: Supply Chain
Prepare for impact: The trillion supply chain shakeup is coming, ready or not. Analysts at Accenture say every business is now a digital business. But the question is: is every supply chain a truly digital supply chain? They say many companies are just putting digital processes on top of traditional practices — re-fitting, re-wiring, [...]
By

Taren Grom, Editor

Distribution and 3PL: Adding Value with a Strategic, Integrated Approach
Q: What value can an end-to-end service value chain that touches all aspects of prescription medicine distribution and support bring to the market? A: An end-to-end service value chain that is truly comprehensive in nature can bring significant value, especially to virtual and emerging pharmaceutical companies.  Many of these companies have years of healthcare experience; [...]
By

Jeff Bedard, Account Executive, Smith Medical Partners & Triplefin

FEEDBACK